EP1257284A4 - Ein universelles vakzin und ein verfahren zur behandlung von krebs mit telomerase reverse transkriptase - Google Patents

Ein universelles vakzin und ein verfahren zur behandlung von krebs mit telomerase reverse transkriptase

Info

Publication number
EP1257284A4
EP1257284A4 EP01912787A EP01912787A EP1257284A4 EP 1257284 A4 EP1257284 A4 EP 1257284A4 EP 01912787 A EP01912787 A EP 01912787A EP 01912787 A EP01912787 A EP 01912787A EP 1257284 A4 EP1257284 A4 EP 1257284A4
Authority
EP
European Patent Office
Prior art keywords
reverse transcriptase
treating cancer
telomerase reverse
universal vaccine
cancer employing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01912787A
Other languages
English (en)
French (fr)
Other versions
EP1257284A1 (de
Inventor
Maurizio Zanetti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Priority claimed from PCT/US2001/005143 external-priority patent/WO2001060391A1/en
Publication of EP1257284A1 publication Critical patent/EP1257284A1/de
Publication of EP1257284A4 publication Critical patent/EP1257284A4/de
Withdrawn legal-status Critical Current

Links

EP01912787A 2000-02-15 2001-02-15 Ein universelles vakzin und ein verfahren zur behandlung von krebs mit telomerase reverse transkriptase Withdrawn EP1257284A4 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
1996-10-31
US78811000A 2000-02-15 2000-02-15
US18268500P 2000-02-15 2000-02-15
US182685P 2000-02-15
PCT/US2001/005143 WO2001060391A1 (en) 2000-02-15 2001-02-15 A universal vaccine and method for treating cancer employing telomerase reverse transcriptase

Publications (2)

Publication Number Publication Date
EP1257284A1 EP1257284A1 (de) 2002-11-20
EP1257284A4 true EP1257284A4 (de) 2005-12-21

Family

ID=27807450

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01912787A Withdrawn EP1257284A4 (de) 2000-02-15 2001-02-15 Ein universelles vakzin und ein verfahren zur behandlung von krebs mit telomerase reverse transkriptase

Country Status (1)

Country Link
EP (1) EP1257284A4 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109069575A (zh) 2016-02-23 2018-12-21 毛里齐奥·扎内蒂 通用癌症疫苗
US11464841B2 (en) * 2016-09-30 2022-10-11 The Trustees Of The University Of Pennsylvania TERT immunogenic compositions and methods of treatment using the same

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994003205A1 (en) * 1992-08-07 1994-02-17 Cytel Corporation Hla binding peptides and their uses
WO1999050392A1 (en) * 1998-03-31 1999-10-07 Geron Corporation Methods and compositions for eliciting an immune response to a telomerase antigen
WO2000002581A1 (en) * 1998-07-08 2000-01-20 Norsk Hydro Asa Antigenic peptides derived from telomerase
WO2000061766A2 (en) * 1999-04-09 2000-10-19 Biomira, Inc. Telomerase-specific cancer vaccine

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994003205A1 (en) * 1992-08-07 1994-02-17 Cytel Corporation Hla binding peptides and their uses
WO1999050392A1 (en) * 1998-03-31 1999-10-07 Geron Corporation Methods and compositions for eliciting an immune response to a telomerase antigen
WO2000002581A1 (en) * 1998-07-08 2000-01-20 Norsk Hydro Asa Antigenic peptides derived from telomerase
WO2000061766A2 (en) * 1999-04-09 2000-10-19 Biomira, Inc. Telomerase-specific cancer vaccine

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
MINEV BORIS ET AL: "Cytotoxic T cell immunity against telomerase reverse transcriptase in humans", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC, US, vol. 97, no. 9, 25 April 2000 (2000-04-25), pages 4796 - 4801, XP002155017, ISSN: 0027-8424 *
See also references of WO0160391A1 *
VONDERHEIDE R H ET AL: "GENERATION OF TELOMERASE-SPECIFIC HLA-A3-RESTRICTED CYTOTOXIC T LYMPHOCYTES FROM PATIENT BLOOD: IMPLICATIONS FOR WIDELY APPLICABLE ANTI-CANCER IMMUNOTHERAPY", BLOOD, W.B. SAUNDERS, PHILADELPHIA, VA, US, vol. 94, no. SUPPL, 1999, pages 677A, XP000971161, ISSN: 0006-4971 *
VONDERHEIDE R H ET AL: "SEARCH FOR UNIVERSAL TUMOR ANTIGENS: POTENTIAL OF THE CATALYTIC TELOMERASE SUBUNIT", BLOOD, W.B. SAUNDERS, PHILADELPHIA, VA, US, vol. 92, no. 10, SUPPL, 15 November 1998 (1998-11-15), pages 500A, XP000971197, ISSN: 0006-4971 *

Also Published As

Publication number Publication date
EP1257284A1 (de) 2002-11-20

Similar Documents

Publication Publication Date Title
EP1309602A4 (de) Malaria immunogen und impfstoff
AU1619202A (en) Secure file transfer method and system
IL213240A0 (en) Method of treatment using lighnd-immunogen conjugates
GB0109537D0 (en) Well treatment fluids and methods for the use thereof
EP1433448A4 (de) Erwärmen eines ballonkatheters und erwärmungsverfahren dafür
GB0015470D0 (en) Malodor counteractants and methods for preparing and using the same
MXPA02001891A (es) Una composicion de vacuna y metodo para utilizacion de la misma.
AU2001280404A1 (en) Method and device for treating inter alia the cervix
EP1370285A4 (de) Vakzinezusammensetzung und verfahren für ihre verwendung
GB2394319B (en) Work transfer method and system
GB2366845B (en) Method and device for the purpose of operating a clutch
AU2001222215A1 (en) Lumbago treating girdle
EP1257284A4 (de) Ein universelles vakzin und ein verfahren zur behandlung von krebs mit telomerase reverse transkriptase
GB2360802B (en) Zero drill completion and production system
HK1043921B (zh) 裝飾用墊片及其製造方法
GB0026838D0 (en) Treatment method
GB0228183D0 (en) Surface treatment tool
GB0026015D0 (en) Cancer treatment
EP1267911A4 (de) Verfahren zur behandlung
GB0028935D0 (en) Secure file transfer method and system
IL153087A0 (en) Systems and methods for treating a mucosal surface
GB2347965B (en) Template and method for use thereof
GB0031321D0 (en) Treatment
GB0000470D0 (en) Templates
GB2357692B (en) Preparation and combination tool

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020910

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL PAYMENT 20020910;LT PAYMENT 20020910;LV PAYMENT 20020910;MK PAYMENT 20020910;RO PAYMENT 20020910;SI PAYMENT 20020910

A4 Supplementary search report drawn up and despatched

Effective date: 20051104

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20090828

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1051150

Country of ref document: HK